AU2003268257A1 - Pharmaceutically enhanced low-energy radiosurgery - Google Patents

Pharmaceutically enhanced low-energy radiosurgery

Info

Publication number
AU2003268257A1
AU2003268257A1 AU2003268257A AU2003268257A AU2003268257A1 AU 2003268257 A1 AU2003268257 A1 AU 2003268257A1 AU 2003268257 A AU2003268257 A AU 2003268257A AU 2003268257 A AU2003268257 A AU 2003268257A AU 2003268257 A1 AU2003268257 A1 AU 2003268257A1
Authority
AU
Australia
Prior art keywords
radiosurgery
energy
enhanced low
pharmaceutically
pharmaceutically enhanced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003268257A
Inventor
Kevin N. Morris
Michael D. Weil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirius Medicine LLC
Original Assignee
Sirius Medicine LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sirius Medicine LLC filed Critical Sirius Medicine LLC
Publication of AU2003268257A1 publication Critical patent/AU2003268257A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/1091—Kilovoltage or orthovoltage range photons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003268257A 2003-08-28 2003-08-28 Pharmaceutically enhanced low-energy radiosurgery Abandoned AU2003268257A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/027102 WO2005030267A1 (en) 2003-08-28 2003-08-28 Pharmaceutically enhanced low-energy radiosurgery

Publications (1)

Publication Number Publication Date
AU2003268257A1 true AU2003268257A1 (en) 2005-04-14

Family

ID=34392790

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003268257A Abandoned AU2003268257A1 (en) 2003-08-28 2003-08-28 Pharmaceutically enhanced low-energy radiosurgery

Country Status (2)

Country Link
AU (1) AU2003268257A1 (en)
WO (1) WO2005030267A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2129437A2 (en) 2007-02-07 2009-12-09 Koninklijke Philips Electronics N.V. Motion compensation in quantitative data analysis and therapy
WO2013009688A1 (en) 2011-07-08 2013-01-17 Bourke Frederic A Phosphors and scintillators for light stimulation within a medium
DE102008034020A1 (en) * 2008-07-16 2010-01-21 Bayer Schering Pharma Aktiengesellschaft Contrast agent enhanced radiotherapy with high performance tubes
WO2010051469A1 (en) * 2008-10-30 2010-05-06 Kenneth Oosting X-ray beam processor
DE102010052613A1 (en) * 2010-11-29 2012-05-31 Stefan Brühl Heavy atoms containing substance, useful in a medical procedure, which is radiation therapy, preferably X-rays, for the treatment of tumors and to increase the biological effect of radiation, preferably X-rays

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6125295A (en) * 1997-08-27 2000-09-26 Cash, Jr.; Webster C. Pharmaceutically enhanced low-energy radiosurgery

Also Published As

Publication number Publication date
WO2005030267A1 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
AUPS054702A0 (en) Cancer therapy
AU2003273865A1 (en) Amino-propanol derivatives
AU2003224654A1 (en) Photodynamic therapy for pre-melanomas
AU2003256378A1 (en) Therapeutic pack
AU2003211362A1 (en) N-hydroxycarboxamide derivative
AU2003276447A1 (en) Inhalers
AU2002951082A0 (en) Therapeutic cellular agents
AU2003294318A1 (en) Therapeutic bioconjugates
AU2003247005A1 (en) Therapy combination
EP2561887B8 (en) Cancer therapy sensitizer
EP1594433A3 (en) Cancer therapy sensitizer
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003215150A1 (en) Therapeutic compounds
AU2003282722A1 (en) Therapeutic compositions
AU2003268257A1 (en) Pharmaceutically enhanced low-energy radiosurgery
AU2003255418A1 (en) Sound synthesiser
AU2003283339A1 (en) Cancer therapy determination
AU2003254043A1 (en) Antifungal therapeutic targets
AU2003231937A1 (en) Therapeutic methods
AU2003292197A1 (en) Lna-cpg conjugates
AU2003264722A1 (en) Methods
AU2003205935A1 (en) Forming means
AU2003902516A0 (en) Therapeutic compositions - II
AU2003271237A1 (en) Therapeutic brassiere
AUPS283402A0 (en) Combination therapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase